In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.

Gemcitabine (GEM) is an anticancer agent widely used in non-small cell lung and pancreatic cancers. The clinical use of GEM has been limited by its rapid metabolism and short plasma half-life. These restrictions lead to frequent administration of high drug doses which can cause severe side effects. Therefore, new delivery strategies are needed aiming toward improved therapeutic effects. Single-walled carbon nanotubes (SWCNTs) are emerging as promising carriers for drug delivery due to their unique properties including high drug loading capacities, notable cell membrane penetrability and prolonged circulation times. In this work, pristine SWCNTs were functionalized through carboxylation, acylation, amination, PEGylation and finally GEM conjugation. The prepared SWCNT-GEM and SWCNT-PEG-GEM conjugates were characterized by FTIR, NMR, DSC and TEM to confirm the successful functionalization. The amount of GEM bound to the conjugates was 43.14% (w/w) for the SWCNT-GEM and 37.32% for the SWCNT-PEG-GEM, indicating high loading capacity. MTT assay on the human lung carcinoma cell line (A549) and the human pancreatic carcinoma cell line (MIA PaCa-2) demonstrated that the SWCNT-GEM was more cytotoxic than SWCNT-PEG-GEM and GEM. The SWCNT-PEG-GEM conjugates afford higher efficacy in suppressing tumor growth than SWCNT-GEM and GEM in B6 nude mice. The results demonstrate that the new formulation of GEM is useful strategy for improving the antitumor efficacy of GEM.

[1]  N. K. Jain,et al.  Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes , 2013, Journal of drug targeting.

[2]  S. Pramod,et al.  Carbon Nanotubes in Pharmaceutical Nanotechnology: An introduction to Future Drug Delivery System , 2013 .

[3]  E. Borowiak‐Palen,et al.  Single-wall carbon nanotubes based anticancer drug delivery system , 2009 .

[4]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[5]  Hongjie Dai,et al.  Supramolecular Chemistry on Water- Soluble Carbon Nanotubes for Drug Loading and Delivery , 2007 .

[6]  You Han Bae,et al.  Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Piercarlo Mustarelli,et al.  PEGylated carbon nanotubes: preparation, properties and applications , 2013 .

[8]  M. Vandana,et al.  Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. , 2010, Biomaterials.

[9]  F Atyabi,et al.  Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube , 2011, International journal of nanomedicine.

[10]  Maurizio Prato,et al.  Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. , 2008, Chemical communications.

[11]  Xiaoke Zhang,et al.  Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. , 2009, Biomaterials.

[12]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[13]  Xiaoke Zhang,et al.  Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. , 2012, Biomaterials.

[14]  S. Stolnik,et al.  PEGylated nanomedicines: recent progress and remaining concerns , 2014, Expert opinion on drug delivery.

[15]  Ren-Shen Lee,et al.  Polymer-grafted multi-walled carbon nanotubes through surface-initiated ring-opening polymerization and click reaction , 2011 .

[16]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[17]  D. Russo,et al.  Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. , 2008, Journal of nanoscience and nanotechnology.

[18]  K. Kiguchi,et al.  In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. , 2011, International journal of pharmaceutics.

[19]  Lin Jia,et al.  Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles. , 2010, World journal of gastroenterology.

[20]  A. Gabizon.  Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.

[21]  S. Filetti,et al.  Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[22]  C. Manegold.  Gemcitabine (Gemzar®) in non-small cell lung cancer , 2004, Expert review of anticancer therapy.

[23]  M. Hussein,et al.  A review on characterizations and biocompatibility of functionalized carbon nanotubes in drug delivery design , 2014 .

[24]  J. Kong,et al.  Tracking the endocytic pathway of recombinant protein toxin delivered by multiwalled carbon nanotubes. , 2010, ACS nano.

[25]  Qiang Zhang,et al.  Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  W. Trickler,et al.  Chitosan and Glyceryl Monooleate Nanostructures Containing Gemcitabine: Potential Delivery System for Pancreatic Cancer Treatment , 2010, AAPS PharmSciTech.

[27]  Nastaran Nafissi-Varcheh,et al.  PEGylated Single-Walled Carbon Nanotubes as Nanocarriers for Cyclosporin A Delivery , 2013, AAPS PharmSciTech.

[28]  P. Caliceti,et al.  Folate-mediated targeting of polymeric conjugates of gemcitabine. , 2006, International journal of pharmaceutics.

[29]  H. Dai,et al.  Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells. , 2004, Journal of the American Chemical Society.

[30]  E. Mini,et al.  Cellular pharmacology of gemcitabine. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  M. Rashad,et al.  Direct precipitation and characterization of ZnO nanoparticles , 2014 .

[32]  J. Gallo,et al.  Selective Protection of 2',2'-Difluorodeoxycytidine (Gemcitabine). , 1999, The Journal of organic chemistry.

[33]  R. Tyagi,et al.  Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  H. Dai,et al.  Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. , 2007, Journal of the American Chemical Society.

[35]  H. Ali-Boucetta,et al.  Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. , 2013, Advanced drug delivery reviews.

[36]  M. Vandana,et al.  Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[37]  Rassoul Dinarvand,et al.  Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study , 2012, International journal of nanomedicine.

[38]  Sanjiv S Gambhir,et al.  A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.

[39]  Hwankyu Lee.  Molecular Modeling of PEGylated Peptides, Dendrimers, and Single-Walled Carbon Nanotubes for Biomedical Applications , 2014 .

[40]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[41]  H. Dai,et al.  Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.

[42]  Sunil Kumar Singh,et al.  Attachment of biomolecules (protein and DNA) to amino-functionalized carbon nanotubes , 2009 .

[43]  F. Atyabi,et al.  Carbon nanotubes-graft-polyglycerol: Biocompatible hybrid materials for nanomedicine , 2009 .

[44]  Weibo Cai,et al.  Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[45]  Mark Voorneveld,et al.  Preparation , 2018, Games Econ. Behav..